India’s Medical Device Divide: New Policy Review Sparks Debate Over Safety and Innovation

NEW DELHI — The Union Health Ministry has launched a high-level committee to overhaul the regulation of refurbished medical devices, a move that has reignited a fierce tug-of-war between domestic manufacturers and multinational corporations. The decision, announced by Minister of State for Health Anupriya Patel in the Rajya Sabha, seeks to resolve a “regulatory whiplash” that has left hospitals, importers, and patients in a legal grey zone regarding the use of pre-owned high-end equipment like MRI scanners and robotic surgical systems.

The committee’s mandate is sweeping: it must define what constitutes a “refurbished” device, establish rigorous safety and performance benchmarks, and dictate how these machines are decommissioned at the end of their lives. While proponents argue that a regulated second-hand market could democratize healthcare in India’s underserved regions, local innovators warn that easing import restrictions could turn the nation into a “dumping ground” for the world’s medical e-waste.

A Regulatory Conflict: The Policy Seesaw

The current tension stems from conflicting signals between two government arms. In 2023, the Ministry of Environment, Forest and Climate Change (MoEFCC) opened a narrow window for importing refurbished high-end devices to reduce electronic waste. However, the Central Drugs Standard Control Organisation (CDSCO) quickly moved to block these imports, noting that existing Medical Devices Rules do not explicitly permit the sale of refurbished goods.

This stalemate has left the Indian medical device market—projected to reach approximately ₹76,000 crore ($9 billion) by 2025—at a crossroads.

The Domestic Stance: Protecting “Make in India”

The Association of Indian Medical Device Industry (AiMeD), representing domestic players, has voiced a sharp “no” to any relaxation of import bans. They argue that without a framework aligned with the International Medical Device Regulators Forum (IMDRF), India risks compromising patient safety and stifling local innovation.

“We strongly oppose any move to relax restrictions on importing refurbished equipment without a robust, enforceable framework,” stated AiMeD in a recent release. Rajiv Nath, AiMeD forum coordinator, points to countries like China and Thailand, which strictly prohibit such imports to protect their domestic manufacturing ecosystems.

Clinical leaders share these concerns. Dr. Sudhir Srivastav, Managing Director of SS Innovations (a domestic robotic surgery firm), emphasizes that in precision-heavy fields, the risk is magnified. “Introducing refurbished systems into robotic surgery without globally benchmarked regulation introduces unacceptable clinical risk,” Dr. Srivastav cautioned.

The Multinational View: Access and Sustainability

Conversely, the Medical Technology Association of India (MTaI), which represents global giants, views the committee as a step toward modernization. They argue that regulated refurbishing—which accounts for 7% to 9% of the medical equipment volume in the U.S. and EU—could be a boon for India.

Pavan Choudary, Chairman of MTaI, suggests that a clear policy could transform India into a global “repair and refurbishing hub,” supporting the government’s Electronics Repair Services Outsourcing (ERSO) initiative. The potential benefits cited by proponents include:

• Cost Reduction: Lowering capital expenditure for hospitals in Tier-2 and Tier-3 cities.

• Workforce Training: Allowing more facilities to afford equipment for hands-on medical education.

• Environmental Logic: Extending the lifecycle of high-value equipment before it hits the landfill.

Patient Safety and the “Transparency Gap”

The most pressing concern for the general public is the lack of transparency in current practices. Currently, an estimated ₹12,000–₹15,000 crore worth of unauthorized trade in pre-owned equipment occurs annually in India.

“Patients rarely know if the CT scanner or dialysis machine being used on them is a decade old or brand new,” says Rajiv Nath. This “transparency gap” prompted a public interest litigation by the Patient Safety and Access Initiative of India Foundation in 2024. Although the Delhi High Court dismissed the petition due to the lack of specific existing regulations, the case highlighted a critical legal vacuum.

Risks vs. Rigor

Medical experts note that refurbished devices are not inherently dangerous, provided they undergo manufacturer-controlled refurbishment. This includes:

1. Software Updates: Ensuring the device is protected against modern cybersecurity threats.

2. Calibration: Verifying that imaging and radiotherapy doses are accurate.

3. Component Replacement: Swapping out worn parts with original equipment manufacturer (OEM) components.

The Path Ahead: Balancing Innovation and Equity

As the committee deliberates, the stakes remain high for India’s healthcare infrastructure. For a hospital administrator in a smaller city like Nagpur or Coimbatore, the ability to purchase a certified, refurbished MRI machine could mean the difference between offering local diagnostics or referring patients to a metro city hundreds of miles away.

However, health policy analysts warn against creating a “two-tier” healthcare system where rural patients are treated on aging equipment while urban centers get the latest technology.

“The goal should be person-centered care,” notes a recent report in the Future Health Journal. “This means ensuring that every piece of equipment, regardless of its ‘birth date,’ meets the same clinical performance standards.”

What Should Patients Ask?

Until the new policy is codified, healthcare consumers are encouraged to be proactive. If undergoing a major procedure or diagnostic test, you may ask your provider:

• Is this equipment refurbished or pre-owned?

• Has it been serviced and certified by the original manufacturer?

• When was the last quality assurance and calibration check performed?

The Health Ministry’s decision will ultimately signal India’s priority: will it lean toward an “Atmanirbhar” (self-reliant) model that favors new local manufacturing, or a “Circular Economy” model that leverages global refurbishment standards to expand immediate access?

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

https://health.economictimes.indiatimes.com/news/medical-devices/domestic-firms-oppose-centres-move-to-reconsider-policy-for-refurbished-med-devices/128110802?utm_source=top_story&utm_medium=homepage